Sky News
@skynews·9.3M subscribers·76.1K videos
Alzheimer's patient shares her cautious optimism for a new drug being trialled in the US
Posted
June 7, 2021
Views
4,094
Likes
39
Comments
31
Engagement
1.71%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
YouTube Description
as posted by the channelSilvia Speight was diagnosed with Alzheimer's disease four years ago, and spoke to Sky News her hope for the newest Alzheimer's trial drug, with her daughter Tanya Ord.
Aducanumab targets amyloid - plaque that builds up in the brains of people with Alzheimer's - helping to slow the onset of the condition.
It is the first treatment to target the cause of the disease, as existing ones only help to ease symptoms.
SUBSCRIBE to our YouTube channel for more videos
Follow us on Twitter
Like us on Facebook
Follow us on Instagram
For more content go to and download our apps
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí
Guests & Subjects Covered
Silvia SpeightTanya Ord AducanumabTwitter LikeFacebook FollowInstagram ForApple Android Sky News
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.